AAAAAA

   
Results: 1-19 |
Results: 19
Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: Relationship to virologic response
Authors: Duong, M Piroth, L Peytavin, G Forte, F Kohli, E Grappin, M Buisson, M Chavanet, P Portier, H
Citation: M. Duong et al., Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: Relationship to virologic response, CLIN INF D, 33(3), 2001, pp. 386-392
Management of therapeutic escape in HIV-infected patients
Authors: Bossi, P Tubiana, R Calvez, V Peytavin, G Katlama, C Bricaire, F
Citation: P. Bossi et al., Management of therapeutic escape in HIV-infected patients, PRESSE MED, 30(16), 2001, pp. 806-812
Indinavir-ritonavir combination: pharmacokinetics and tolerance in patients with HIV infection
Authors: Bani-Sadr, F Perre, P Peytavin, G Bernard, L Melchior, JC Perronne, C de Truchis, P
Citation: F. Bani-sadr et al., Indinavir-ritonavir combination: pharmacokinetics and tolerance in patients with HIV infection, PRESSE MED, 30(15), 2001, pp. 731-735
Indinavir hair concentration in highly active antiretroviral therapy-treated patients: association with viral load and drug resistance
Authors: Servais, J Peytavin, G Arendt, V Staub, T Schneider, F Hemmer, R Burtonboy, G Schmit, JC
Citation: J. Servais et al., Indinavir hair concentration in highly active antiretroviral therapy-treated patients: association with viral load and drug resistance, AIDS, 15(7), 2001, pp. 941-943
Effect of stavudine on mitochondrial genome and fatty acid oxidation in lean and obese mice
Authors: Gaou, I Malliti, M Guimont, MC Letteron, P Demeilliers, C Peytavin, G Degott, C Pessayre, D Fromenty, B
Citation: I. Gaou et al., Effect of stavudine on mitochondrial genome and fatty acid oxidation in lean and obese mice, J PHARM EXP, 297(2), 2001, pp. 516-523
Conduction disturbances associated with venlafaxine
Authors: Combes, A Peytavin, G Theron, D
Citation: A. Combes et al., Conduction disturbances associated with venlafaxine, ANN INT MED, 134(2), 2001, pp. 166-167
Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model
Authors: Forestier, F de Renty, P Peytavin, G Dohin, E Farinotti, R Mandelbrot, L
Citation: F. Forestier et al., Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model, AM J OBST G, 185(1), 2001, pp. 178-181
Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women
Authors: Mandelbrot, L Peytavin, G Firtion, G Farinotti, R
Citation: L. Mandelbrot et al., Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women, AM J OBST G, 184(2), 2001, pp. 153-158
Phenotypic resistance to protease inhibitors in patients who fail on highly active antitetroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz
Authors: Piketty, C Race, E Castiel, P Belec, L Peytavin, G Si-Mohamed, A Gonzalez-Canali, G Weiss, L Clavel, F Kazatchkine, MD
Citation: C. Piketty et al., Phenotypic resistance to protease inhibitors in patients who fail on highly active antitetroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz, AIDS, 14(5), 2000, pp. 626-628
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy
Authors: Descamps, D Flandre, P Calvez, V Peytavin, G Meiffredy, V Collin, G Delaugerre, C Robert-Delmas, S Bazin, B Aboulker, JP Pialoux, G Raffi, F Brun-Vezinet, F
Citation: D. Descamps et al., Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy, J AM MED A, 283(2), 2000, pp. 205-211
Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial)is not associated with mutations conferring viral resistance
Authors: Mouroux, M Yvon-Groussin, A Peytavin, G Delaugerre, C Legrand, M Bossi, P Do, B Trylesinski, A Diquet, B Dohin, E Delfraissy, JF Katlama, C Calvez, V
Citation: M. Mouroux et al., Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial)is not associated with mutations conferring viral resistance, J CLIN MICR, 38(7), 2000, pp. 2726-2730
Efavirenz induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir
Authors: Duval, X Le Moing, V Longuet, P Leport, C Vilde, JL Lamotte, C Peytavin, G Farinotti, R
Citation: X. Duval et al., Efavirenz induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir, ANTIM AG CH, 44(9), 2000, pp. 2593-2593
Placental transfer of pyrimethamine studied in an ex vivo placental perfusion model
Authors: Peytavin, G Leng, JJ Forestier, F Saux, MC Hohlfeld, P Farinotti, R
Citation: G. Peytavin et al., Placental transfer of pyrimethamine studied in an ex vivo placental perfusion model, BIOL NEONAT, 78(2), 2000, pp. 83-85
Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection
Authors: Lamotte, C Peytavin, G Farinotti, R
Citation: C. Lamotte et al., Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection, J CHROMAT B, 735(2), 1999, pp. 159-170
Experience of once daily nevirapine in 93 HIV-infected patients.
Authors: Allavena, C Francois, C Reliquet, V Perre, P Michau, C Peytavin, G Raffi, F
Citation: C. Allavena et al., Experience of once daily nevirapine in 93 HIV-infected patients., PATH BIOL, 47(5), 1999, pp. 563-565
Renin-angiotensin system inhibition in a patient having an overdose of HIVprotease inhibitor
Authors: Duval, X Peytavin, G Fouqueray, B Leport, C Vilde, JL
Citation: X. Duval et al., Renin-angiotensin system inhibition in a patient having an overdose of HIVprotease inhibitor, AIDS, 13(14), 1999, pp. 1983-1984
Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy
Authors: Piketty, C Race, E Castiel, P Belec, L Peytavin, G Si-Mohamed, A Gonzalez-Canali, G Weiss, L Clavel, F Kazatchkine, MD
Citation: C. Piketty et al., Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy, AIDS, 13(11), 1999, pp. F71-F77
Kinetics of antiviral activity and intracellular pharmacokinetics of humanimmunodeficiency virus type 1 protease inhibitors in tissue culture
Authors: Nascimbeni, M Lamotte, C Peytavin, G Farinotti, R Clavel, F
Citation: M. Nascimbeni et al., Kinetics of antiviral activity and intracellular pharmacokinetics of humanimmunodeficiency virus type 1 protease inhibitors in tissue culture, ANTIM AG CH, 43(11), 1999, pp. 2629-2634
Aging prolongs recovery of psychomotor functions at emergence from propofol-alfentanil anaesthesia
Authors: Keita, H Peytavin, G Giraud, O Silleran, J Rahoeliarivaraux, L Desmonts, JM Mantz, J
Citation: H. Keita et al., Aging prolongs recovery of psychomotor functions at emergence from propofol-alfentanil anaesthesia, CAN J ANAES, 45(12), 1998, pp. 1211-1214
Risultati: 1-19 |